Report cover image

Top 5 Emerging Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027

Publisher MarketLine
Published Oct 25, 2023
Length 137 Pages
SKU # MTLN18362562

Description

Top 5 Emerging Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027


Summary

The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • These countries contributed $288.2 billion to the global pharmaceuticals industry in 2022, with a compound annual growth rate (CAGR) of 9.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $451.7 billion in 2027, with a CAGR of 9.4% over the 2022-27 period.
  • Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $213.2 billion in 2022. This was followed by Mexico and India with a value of $25.5 and $24.2 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $355.2 billion in 2027, followed by Mexico and India with expected values of $37.8 and $32.6 billion, respectively.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to Buy
  • What was the size of the emerging five pharmaceuticals market by value in 2022?
  • What will be the size of the emerging five pharmaceuticals market in 2027?
  • What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the emerging five pharmaceuticals market?

Table of Contents

137 Pages
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Pharmaceuticals in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. Aspen Pharmacare Holdings Ltd
13.2. Adcock Ingram Holdings Ltd
13.3. Novartis AG
13.4. Ache Laboratorios Farmaceuticos SA
13.5. EMS Sigma Pharma
13.6. Yangtze River Pharmaceutical Group
13.7. Shanghai Pharmaceuticals Holding Co Ltd
13.8. Yunnan Baiyao Group Co Ltd
13.9. Guangzhou Pharmaceutical Holdings Ltd
13.10. Sun Pharmaceutical Industries Ltd
13.11. Lupin Ltd
13.12. Dr. Reddy's Laboratories Limited
13.13. Aurobindo Pharma Ltd
13.14. Sanofi SA
13.15. Genomma Lab Internacional SAB de CV
13.16. Pfizer Inc.
14 Appendix
14.1. Methodology
14.2. About MarketLine
List of Tables
Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-27
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-22
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2022-27
Table 4: South Africa pharmaceuticals market value: $ billion, 2017-22
Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2022
Table 6: South Africa pharmaceuticals market value forecast: $ billion, 2022–27
Table 7: South Africa size of population (million), 2018–22
Table 8: South Africa gdp (constant 2005 prices, $ billion), 2018–22
Table 9: South Africa gdp (current prices, $ billion), 2018–22
Table 10: South Africa inflation, 2018–22
Table 11: South Africa consumer price index (absolute), 2018–22
Table 12: South Africa exchange rate, 2018–22
Table 13: Brazil pharmaceuticals market value: $ billion, 2017-22
Table 14: Brazil pharmaceuticals market geography segmentation: $ billion, 2022
Table 15: Brazil pharmaceuticals market value forecast: $ billion, 2022–27
Table 16: Brazil size of population (million), 2018–22
Table 17: Brazil gdp (constant 2005 prices, $ billion), 2018–22
Table 18: Brazil gdp (current prices, $ billion), 2018–22
Table 19: Brazil inflation, 2018–22
Table 20: Brazil consumer price index (absolute), 2018–22
Table 21: Brazil exchange rate, 2018–22
Table 22: China pharmaceuticals market value: $ billion, 2017-22
Table 23: China pharmaceuticals market geography segmentation: $ billion, 2022
Table 24: China pharmaceuticals market value forecast: $ billion, 2022–27
Table 25: China size of population (million), 2018–22
Table 26: China gdp (constant 2005 prices, $ billion), 2018–22
Table 27: China gdp (current prices, $ billion), 2018–22
Table 28: China inflation, 2018–22
Table 29: China consumer price index (absolute), 2018–22
Table 30: China exchange rate, 2018–22
Table 31: India pharmaceuticals market value: $ billion, 2017-22
Table 32: India pharmaceuticals market geography segmentation: $ billion, 2022
Table 33: India pharmaceuticals market value forecast: $ billion, 2022–27
Table 34: India size of population (million), 2018–22
Table 35: India gdp (constant 2005 prices, $ billion), 2018–22
Table 36: India gdp (current prices, $ billion), 2018–22
Table 37: India inflation, 2018–22
Table 38: India consumer price index (absolute), 2018–22
Table 39: India exchange rate, 2018–22
Table 40: Mexico pharmaceuticals market value: $ billion, 2017-22
Table 41: Mexico pharmaceuticals market geography segmentation: $ billion, 2022
Table 42: Mexico pharmaceuticals market value forecast: $ billion, 2022–27
Table 43: Mexico size of population (million), 2018–22
Table 44: Mexico gdp (constant 2005 prices, $ billion), 2018–22
Table 45: Mexico gdp (current prices, $ billion), 2018–22
Table 46: Mexico inflation, 2018–22
Table 47: Mexico consumer price index (absolute), 2018–22
Table 48: Mexico exchange rate, 2018–22
Table 49: Aspen Pharmacare Holdings Ltd: key facts
Table 50: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 51: Aspen Pharmacare Holdings Ltd: Key Employees
Table 52: Adcock Ingram Holdings Ltd: key facts
Table 53: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 54: Adcock Ingram Holdings Ltd: Key Employees
Table 55: Novartis AG: key facts
Table 56: Novartis AG: Annual Financial Ratios
Table 57: Novartis AG: Key Employees
Table 58: Novartis AG: Key Employees Continued
Table 59: Ache Laboratorios Farmaceuticos SA: key facts
Table 60: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 61: EMS Sigma Pharma: key facts
Table 62: EMS Sigma Pharma: Key Employees
Table 63: Yangtze River Pharmaceutical Group: key facts
Table 64: Yangtze River Pharmaceutical Group: Key Employees
Table 65: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 66: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 67: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 68: Yunnan Baiyao Group Co Ltd: key facts
Table 69: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios
Table 70: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 71: Guangzhou Pharmaceutical Holdings Ltd: Key Employees
Table 72: Sun Pharmaceutical Industries Ltd: key facts
Table 73: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 74: Sun Pharmaceutical Industries Ltd: Key Employees
Table 75: Sun Pharmaceutical Industries Ltd: Key Employees Continued
Table 76: Lupin Ltd: key facts
Table 77: Lupin Ltd: Annual Financial Ratios
Table 78: Lupin Ltd: Key Employees
Table 79: Dr. Reddy's Laboratories Limited: key facts
Table 80: Dr. Reddy's Laboratories Limited: Annual Financial Ratios
Table 81: Dr. Reddy's Laboratories Limited: Key Employees
Table 82: Aurobindo Pharma Ltd: key facts
Table 83: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 84: Aurobindo Pharma Ltd: Key Employees
Table 85: Sanofi SA: key facts
Table 86: Sanofi SA: Annual Financial Ratios
Table 87: Sanofi SA: Key Employees
Table 88: Sanofi SA: Key Employees Continued
Table 89: Genomma Lab Internacional SAB de CV: key facts
Table 90: Genomma Lab Internacional SAB de CV: Annual Financial Ratios
Table 91: Genomma Lab Internacional SAB de CV: Key Employees
Table 92: Pfizer Inc.: key facts
Table 93: Pfizer Inc.: Annual Financial Ratios
Table 94: Pfizer Inc.: Key Employees
Table 95: Pfizer Inc.: Key Employees Continued
Table 96: Maypo Farmaceutics SA de CV: key facts
List of Figures
Figure 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-27
Figure 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-22
Figure 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2022-27
Figure 4: South Africa pharmaceuticals market value: $ billion, 2017-22
Figure 5: South Africa pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 6: South Africa pharmaceuticals market value forecast: $ billion, 2022–27
Figure 7: Forces driving competition in the pharmaceuticals market in South Africa, 2022
Figure 8: Drivers of buyer power in the pharmaceuticals market in South Africa, 2022
Figure 9: Drivers of supplier power in the pharmaceuticals market in South Africa, 2022
Figure 10: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2022
Figure 11: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2022
Figure 12: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2022
Figure 13: Brazil pharmaceuticals market value: $ billion, 2017-22
Figure 14: Brazil pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 15: Brazil pharmaceuticals market value forecast: $ billion, 2022–27
Figure 16: Forces driving competition in the pharmaceuticals market in Brazil, 2022
Figure 17: Drivers of buyer power in the pharmaceuticals market in Brazil, 2022
Figure 18: Drivers of supplier power in the pharmaceuticals market in Brazil, 2022
Figure 19: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2022
Figure 20: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2022
Figure 21: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2022
Figure 22: China pharmaceuticals market value: $ billion, 2017-22
Figure 23: China pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 24: China pharmaceuticals market value forecast: $ billion, 2022–27
Figure 25: Forces driving competition in the pharmaceuticals market in China, 2022
Figure 26: Drivers of buyer power in the pharmaceuticals market in China, 2022
Figure 27: Drivers of supplier power in the pharmaceuticals market in China, 2022
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2022
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2022
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in China, 2022
Figure 31: India pharmaceuticals market value: $ billion, 2017-22
Figure 32: India pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 33: India pharmaceuticals market value forecast: $ billion, 2022–27
Figure 34: Forces driving competition in the pharmaceuticals market in India, 2022
Figure 35: Drivers of buyer power in the pharmaceuticals market in India, 2022
Figure 36: Drivers of supplier power in the pharmaceuticals market in India, 2022
Figure 37: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2022
Figure 38: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2022
Figure 39: Drivers of degree of rivalry in the pharmaceuticals market in India, 2022
Figure 40: Mexico pharmaceuticals market value: $ billion, 2017-22
Figure 41: Mexico pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 42: Mexico pharmaceuticals market value forecast: $ billion, 2022–27
Figure 43: Forces driving competition in the pharmaceuticals market in Mexico, 2022
Figure 44: Drivers of buyer power in the pharmaceuticals market in Mexico, 2022
Figure 45: Drivers of supplier power in the pharmaceuticals market in Mexico, 2022
Figure 46: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2022
Figure 47: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2022
Figure 48: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2022

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us